Hanses, F.; Dolff, S.; Trauth, J.; Seimetz, M.; Hagel, S.
A Multicentre, Prospective, and Retrospective Registry to Characterize the Use, Effectiveness, and Safety of Dalbavancin in German Clinical Practice. Antibiotics 2022, 11, 563.
https://doi.org/10.3390/antibiotics11050563
AMA Style
Hanses F, Dolff S, Trauth J, Seimetz M, Hagel S.
A Multicentre, Prospective, and Retrospective Registry to Characterize the Use, Effectiveness, and Safety of Dalbavancin in German Clinical Practice. Antibiotics. 2022; 11(5):563.
https://doi.org/10.3390/antibiotics11050563
Chicago/Turabian Style
Hanses, Frank, Sebastian Dolff, Janina Trauth, Michael Seimetz, and Stefan Hagel.
2022. "A Multicentre, Prospective, and Retrospective Registry to Characterize the Use, Effectiveness, and Safety of Dalbavancin in German Clinical Practice" Antibiotics 11, no. 5: 563.
https://doi.org/10.3390/antibiotics11050563
APA Style
Hanses, F., Dolff, S., Trauth, J., Seimetz, M., & Hagel, S.
(2022). A Multicentre, Prospective, and Retrospective Registry to Characterize the Use, Effectiveness, and Safety of Dalbavancin in German Clinical Practice. Antibiotics, 11(5), 563.
https://doi.org/10.3390/antibiotics11050563